Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine how 25(OH)D3 clearance is affected by vitamin D3
supplementation using a gold standard pharmacokinetic approach.
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Calcifediol Cholecalciferol Ergocalciferols Hydroxycholecalciferols Vitamin D Vitamins